These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1372 related items for PubMed ID: 17259873

  • 1. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ, Klugman KP, Pichichero M.
    Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
    [Abstract] [Full Text] [Related]

  • 2. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF, Katz-Gaynor K, Barton T, Ahmad N, Ghaffar F, Rasko D, McCracken GH.
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [Abstract] [Full Text] [Related]

  • 3. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.
    Richter SS, Heilmann KP, Dohrn CL, Riahi F, Beekmann SE, Doern GV.
    Clin Infect Dis; 2009 Feb 01; 48(3):e23-33. PubMed ID: 19115971
    [Abstract] [Full Text] [Related]

  • 4. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.
    Moore MR, Gertz RE, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, Gershman K, Reingold A, Farley M, Harrison LH, Hadler JL, Bennett NM, Thomas AR, McGee L, Pilishvili T, Brueggemann AB, Whitney CG, Jorgensen JH, Beall B.
    J Infect Dis; 2008 Apr 01; 197(7):1016-27. PubMed ID: 18419539
    [Abstract] [Full Text] [Related]

  • 5. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
    Hsu KK, Shea KM, Stevenson AE, Pelton SI, Massachusetts Department of Public Health.
    Pediatr Infect Dis J; 2010 Apr 01; 29(4):289-93. PubMed ID: 19935447
    [Abstract] [Full Text] [Related]

  • 6. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine.
    Jacobs MR, Good CE, Bajaksouzian S, Windau AR.
    Clin Infect Dis; 2008 Dec 01; 47(11):1388-95. PubMed ID: 18959493
    [Abstract] [Full Text] [Related]

  • 7. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.
    Pai R, Moore MR, Pilishvili T, Gertz RE, Whitney CG, Beall B, Active Bacterial Core Surveillance Team.
    J Infect Dis; 2005 Dec 01; 192(11):1988-95. PubMed ID: 16267772
    [Abstract] [Full Text] [Related]

  • 8. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.
    Techasaensiri C, Messina AF, Katz K, Ahmad N, Huang R, McCracken GH.
    Pediatr Infect Dis J; 2010 Apr 01; 29(4):294-300. PubMed ID: 19949357
    [Abstract] [Full Text] [Related]

  • 9. Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine.
    Aguiar SI, Serrano I, Pinto FR, Melo-Cristino J, Ramirez M, Portuguese Surveillance Group for the Study of Respiratory Pathogens.
    Clin Microbiol Infect; 2008 Sep 01; 14(9):835-43. PubMed ID: 18844684
    [Abstract] [Full Text] [Related]

  • 10. Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children.
    Park SY, Moore MR, Bruden DL, Hyde TB, Reasonover AL, Harker-Jones M, Rudolph KM, Hurlburt DA, Parks DJ, Parkinson AJ, Schuchat A, Hennessy TW.
    Pediatr Infect Dis J; 2008 Apr 01; 27(4):335-40. PubMed ID: 18316986
    [Abstract] [Full Text] [Related]

  • 11. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.
    Muñoz-Almagro C, Jordan I, Gene A, Latorre C, Garcia-Garcia JJ, Pallares R.
    Clin Infect Dis; 2008 Jan 15; 46(2):174-82. PubMed ID: 18171247
    [Abstract] [Full Text] [Related]

  • 12. Distribution of capsular serotypes and macrolide resistance mechanisms among macrolide-resistant Streptococcus pneumoniae isolates in Korea.
    Bae S, Lee K.
    Diagn Microbiol Infect Dis; 2009 Feb 15; 63(2):213-6. PubMed ID: 19097840
    [Abstract] [Full Text] [Related]

  • 13. Serotype 19A is the most common Streptococcus pneumoniae isolate in children with chronic sinusitis.
    McNeil JC, Hulten KG, Mason EO, Kaplan SL.
    Pediatr Infect Dis J; 2009 Sep 15; 28(9):766-8. PubMed ID: 19636285
    [Abstract] [Full Text] [Related]

  • 14. Serotype distribution and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from children in China younger than 5 years.
    Liu Y, Wang H, Chen M, Sun Z, Zhao R, Zhang L, Wang H, Zhang H, Wang L, Chu Y, Liu Y, Ni Y.
    Diagn Microbiol Infect Dis; 2008 Jul 15; 61(3):256-63. PubMed ID: 18358662
    [Abstract] [Full Text] [Related]

  • 15. Serotype distribution and antibiotic resistance of 140 pneumococcal isolates from pediatric patients with upper respiratory infections in Beijing, 2010.
    Zhou L, Yu SJ, Gao W, Yao KH, Shen AD, Yang YH.
    Vaccine; 2011 Oct 13; 29(44):7704-10. PubMed ID: 21839135
    [Abstract] [Full Text] [Related]

  • 16. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?
    Fenoll A, Aguilar L, Granizo JJ, Giménez MJ, Aragoneses-Fenoll L, Mendez C, Tarragó D.
    J Antimicrob Chemother; 2008 Dec 13; 62(6):1430-3. PubMed ID: 18819966
    [Abstract] [Full Text] [Related]

  • 17. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ.
    Clin Microbiol Infect; 2009 Apr 13; 15 Suppl 3():4-6. PubMed ID: 19366362
    [Abstract] [Full Text] [Related]

  • 18. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
    Dagan R.
    Clin Microbiol Infect; 2009 Apr 13; 15 Suppl 3():16-20. PubMed ID: 19366365
    [Abstract] [Full Text] [Related]

  • 19. Emergence of antimicrobial-resistant serotype 19A Streptococcus pneumoniae--Massachusetts, 2001-2006.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2007 Oct 19; 56(41):1077-80. PubMed ID: 17947966
    [Abstract] [Full Text] [Related]

  • 20. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.
    Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, Jackson D, Thomas A, Beall B, Lynfield R, Reingold A, Farley MM, Whitney CG.
    J Infect Dis; 2007 Nov 01; 196(9):1346-54. PubMed ID: 17922399
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 69.